Delivery Order SPE2DB22D1017-SPE2DB25FF1LS

Award Date 12/16/24
Potential Completion Date 12/17/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF1LS
    Delivery Order

This federal contract award, valued at $3,440.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (SPE2DB22D1017|SPE2DB25FF1LS) for the supply of 4,566,736,110 units of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has extensive experience supplying pharmaceutical products and medical supplies to federal government agencies, particularly the DLA Troop Support Medical. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/17/25, 9:46 AM